Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Cpd-1224 | 2891620-68-9 | 99.8% | 855.40 | C43H47ClN8O7S | 10 MG
SDP

Supplier:  Medchemexpress LLC HY15338610MG

Encompass_Preferred

CPD-1224 is an orally active small-molecule inhibitor of anaplastic lymphoma kinase (ALK) that links an ALK-binding moiety to a cereblon ligand to induce target degradation. It degrades EML4-ALK and resistant mutant forms, shows tumor growth inhibition in preclinical studies, and is supplied for research applications.

  • Orally active anaplastic lymphoma kinase (ALK) inhibitor that promotes target degradation.
  • Effective against resistance mutations L1196M and G1202R.
  • High purity (>99.8%) suitable for analytical and biological assays.
  • Soluble in DMSO at approximately 14.29 mg/mL for in vitro studies.
  • Available in small-molecule quantities for preclinical research.

Catalog No. 50-002-86994


May include imposed supplier surcharges.
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.